Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

A new mouse model effectively mimics vitiligo for research and drug testing.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

CD34 is crucial for skin tumor development in mice.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

CD34 marks potential stem cells in dog hair follicles.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

The role of γδT-cells in causing alopecia areata remains unclear.

Targeting specific T cells may help treat alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Alopecia areata involves specific immune cells, offering potential treatment targets.